Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study. - Wikidata - awgldk - TriplyDB

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

http://www.wikidata.org/entity/Q34489342

about

Serum uric acid levels in patients with Parkinson's disease: A meta-analysis Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Impact of serum uric acid, albumin and their interaction on Parkinson's disease.Application of high-field magnetic resonance imaging in Parkinson's disease.The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease.

P2860

Q36314912-0F5B4E8B-470B-40B8-B458-67CF43E87E99 Q36374541-D68F7B66-ABB4-443D-AD7A-90208D669CBE Q39160627-B8550341-A391-4F65-99EF-FA6C912FDBDC Q42247149-F6DCF46D-065B-4E91-8E87-1C525A59E29C Q48432793-EE920B46-F83C-4018-8409-CD5F7BDA9945

P2860

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

http://www.wikidata.org/entity/Q34489342

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@ast

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@en

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@nl

type

label

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@ast

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@en

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@nl

altLabel

Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study

@en

prefLabel

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@ast

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@en

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@nl

P1433

Q34489342-BC085039-E474-463D-A4F0-21A0553EF0A6

P1476

Q34489342-5C18F95F-E26A-4489-A3AB-2FFF6C4863A1

P2093

Q34489342-33A17F9D-EDB2-432E-B91E-A41704212A66

Q34489342-40DE4461-408E-40F7-9D0A-52DAE7C91586

P2860

Q34489342-01798144-B9DF-4483-90AD-E88E461DEBC3

Q34489342-1C0A7017-17BD-450F-A8A5-0D3D26DB7E8D

Q34489342-1D40C92B-D8C0-4A29-91D6-59D11AF24FFE

Q34489342-24BC848B-D0FC-4FCA-BCFC-91CE4AF8DED3

Q34489342-2AB43FC0-3439-4373-BACD-8C799AB74D85

Q34489342-2AF25CF6-3520-423D-9964-CFE525221440

Q34489342-338450AE-10F6-43CA-866C-3C7CD861B321

Q34489342-4E16ED41-C363-47EA-B18E-BE247DC23789

Q34489342-4EC3D43E-2E6B-486C-A452-4309F465606D

Q34489342-65A6EECC-61DF-4462-B6D6-C5810B9B2E37

P304

Q34489342-E0CEAF1E-01B1-440A-8B2A-6E830F54F4DF

P31

Q34489342-49A84D70-524F-4EA8-ACB2-7A07707D7DE8

P356

Q34489342-CC6D66FD-BE03-4F35-8634-52DC8F8EF963

P407

Q34489342-D559FB3E-A841-4720-AE9E-8C0DE8CBEC05

P433

Q34489342-1BA79FE6-3125-4A19-B5BE-4F70B43CF140

P478

Q34489342-507190FA-0223-4026-B76F-5156D657D829

P577

Q34489342-687B4AC8-205D-4320-A6B9-F2C98D730A0A

P5875

Q34489342-8D41D5FA-4CD9-4DA6-BE09-98F7A4878F95

P698

Q34489342-A9CB6530-1267-4162-AF73-A3FAD519AC34

P921

Q34489342-4125675C-223F-4848-9DCC-07CB48559912

P932

Q34489342-7B31064F-C19F-4A83-A48A-DCE0466F44B7

P356

JOURNAL.PONE.0112512

P1433

P1476

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study.

@en

P2093

Jae-Hyeok Lee

http://www.w3.org/2001/XMLSchema#string

Tae-Hyoung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition

Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction

Evaluation of brain iron content based on magnetic resonance imaging (MRI): comparison among phase value, R2* and magnitude signal intensity

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

Iron metabolism in Parkinsonian syndromes.

Uric acid as a CNS antioxidant

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.

Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

Low serum urate levels are associated to female gender in multiple sclerosis patients.

P304

e112512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0112512

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268230529

http://www.w3.org/2001/XMLSchema#string

P698

25386854

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4227693

http://www.w3.org/2001/XMLSchema#string